1st time CX Symposium. Presentations, Q&A and #collaboration are 2nd to none. Thank you Erin Murphy, Manj Gohel, & Stephen Black for the invitation! Go to CX2025 if you have the opportunity! frank arko Andrew SP Sharp

Heparin Resistance — Clinical Perspectives and Management Strategies | New England Journal of Medicine nejm.org/doi/full/10.10…

EMEA HCPs: Attention all Charing Cross attendees! Join us for our VTE symposium with Prof. Black, Prof. Sharp, and Dr. Desai; 24 April 9:40-10:10. Don’t miss out on this enlightening session!
#CAVT #Lightning12 ⚡
Rx only. Risk info: peninc.info/risk

#ACC24 Round Up: Ten Original Articles were simultaneously published in NEJM and presented at this year’s American College of Cardiology Scientific Sessions in Atlanta. View the full thread for all American College of Cardiology articles and bookmark this post for future reference.

Occasionally, in TAVI, straightening out tortuous iliac arteries with stiff wires/14Fr sheathes can produce refractory vasovagals. Atropine barely touches it. Only solution is to get the case done and sheath out. This was another example - can see the stress on the sheath

Message from PREVENT study seems to be that we can offer STEMI patients plaque-based revasc of bystander lesions now, or ischaemia-based revasc later, and there might be a small price to pay for the latter. It’s easier for everyone to do it at the index admission, isn’t it? #ACC24

This is an important point - we are around 50:50 for BEV/SEV in our centre. If we entered an industry trial where we were using only one valve, our results would be selective, or possibly worse than they are in the real world, where device choice matters.

Amazing to see a brilliant friend and colleague Michael Foley present the #ORBITA -COSMIC trial of the coronary sinus reducer with simultaneous publication in The Lancet Rasha Al-Lamee NHLI Imperial NHS 💙 #ACC2024

thelancet.com/journals/lance…

Some discussion about late events in Dangershock. Looks like a 6% actual risk reduction in death at 30 days. I’ll take that.

Miracle on RCT street. A randomised trial in cardiogenic shock shows benefit!